Mo Liu Selected Research

Caspase 3 (Caspase-3)

12/2017

PCPA protects against monocrotaline-induced pulmonary arterial remodeling in rats: potential roles of connective tissue growth factor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mo Liu Research Topics

Disease

17	Neoplasms (Cancer) 12/2023 - 10/2009
6	Carcinogenesis 05/2023 - 02/2010
5	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2012
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 02/2012
3	Inflammation (Inflammations) 01/2022 - 01/2016
3	Hepatocellular Carcinoma (Hepatoma) 11/2016 - 07/2016
2	Neuroinflammatory Diseases 01/2024 - 01/2023
2	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 01/2023
2	Pain (Aches) 09/2023 - 04/2023
2	Postoperative Pain 09/2023 - 04/2023
2	Fatty Liver 05/2023 - 01/2022
2	Asthma (Bronchial Asthma) 11/2022 - 01/2021
2	Hemorrhage 01/2022 - 01/2012
2	Osteosarcoma (Osteogenic Sarcoma) 12/2021 - 01/2018
2	Liver Neoplasms (Liver Cancer) 11/2016 - 07/2016
2	Hodgkin Disease (Hodgkin's Disease) 10/2014 - 09/2013
2	Virus Diseases (Viral Diseases) 12/2006 - 09/2005
1	Stomach Neoplasms (Stomach Cancer) 12/2023
1	Spinal Cord Injuries (Spinal Cord Injury) 11/2023
1	Benign Paroxysmal Positional Vertigo 10/2023
1	Vitamin D Deficiency 10/2023
1	Pathologic Processes 01/2023
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Genomic Instability 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Rothmund-Thomson Syndrome (Syndrome, Rothmund-Thomson) 12/2021
1	Periodontitis 01/2021
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Cholangiocarcinoma 08/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2018
1	Pulmonary Arterial Hypertension 01/2018
1	Retinoblastoma (Glioblastoma, Retinal) 01/2018
1	Hypertension (High Blood Pressure) 12/2017
1	Vascular Remodeling 12/2017
1	Hypertrophy 12/2017
1	Pre-Eclampsia (Preeclampsia) 01/2016

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2006
3	Long Noncoding RNAIBA 01/2021 - 01/2018
2	Acetyl Coenzyme A (Acetyl-CoA)IBA 05/2023 - 01/2022
2	Liposomes (Liposome)IBA 01/2023 - 08/2016
2	OvalbuminIBA 11/2022 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 02/2020 - 02/2012
2	Biomarkers (Surrogate Marker)IBA 02/2020 - 01/2018
2	MicroRNAs (MicroRNA)IBA 01/2019 - 08/2018
2	TOR Serine-Threonine KinasesIBA 08/2016 - 02/2010
2	Brentuximab VedotinIBA 10/2014 - 09/2013
1	Fibrinogen (Factor I)FDA Link 02/2024
1	isoborneol (borneol)IBA 01/2024
1	schizandrin BIBA 01/2024
1	MicellesIBA 01/2024
1	CateninsIBA 12/2023
1	Oxygen (Dioxygen)IBA 11/2023
1	Uric Acid (Urate)IBA 10/2023
1	Vitamin D FDA LinkGeneric 10/2023
1	hydroxide ionIBA 10/2023
1	N-methyladenosineIBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	Angiopep-2IBA 01/2023
1	Histones (Histone)IBA 01/2022
1	squamous cell carcinoma-related antigenIBA 01/2022
1	AntigensIBA 01/2022
1	Carcinoembryonic AntigenIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2022
1	Mutant Proteins (Protein, Mutant)IBA 01/2022
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 12/2021
1	SmokeIBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Claudin-2IBA 01/2021
1	AnkyrinsIBA 01/2021
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021
1	Saline SolutionIBA 01/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2018
1	Decitabine FDA Link 02/2018
1	Untranslated RNA (Noncoding RNA)IBA 01/2018
1	E2F Transcription FactorsIBA 01/2018
1	Caspase 3 (Caspase-3)IBA 12/2017
1	Serotonin (5 Hydroxytryptamine)IBA 12/2017
1	MonocrotalineIBA 12/2017
1	Connective Tissue Growth FactorIBA 12/2017
1	Environmental CarcinogensIBA 10/2017
1	Sorafenib (BAY 43-9006)FDA Link 11/2016
1	Mechanistic Target of Rapamycin Complex 1IBA 08/2016
1	CeramidesIBA 08/2016
1	Toll-Like Receptor 4IBA 01/2016

Therapy/Procedure

3	Therapeutics 11/2023 - 01/2018
2	Tonsillectomy 09/2023 - 04/2023
2	Neoadjuvant Therapy 01/2022 - 02/2020
2	Drug Therapy (Chemotherapy) 07/2016 - 09/2013
1	Hyperbaric Oxygenation 11/2023
1	Aftercare (After-Treatment) 01/2022
1	Blood Transfusion (Blood Transfusions) 01/2022
1	Hysterectomy 01/2022
1	Length of Stay 01/2022
1	Oral Administration 08/2016
1	Combination Drug Therapy (Combination Chemotherapy) 07/2016